secwatch.observer — SEC 8-K summary
======================================

Issuer:     WATERS CORP /DE/ (WAT)
CIK:        0001000697
Form:       8-K
Filed at:   2025-11-04T23:59:59+00:00
Accession:  0001193125-25-263520
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Waters Q3 sales $800M (+8% YoY), non-GAAP EPS $3.40 (+16%), raises FY guidance
------------------------------------------------------------------------------

- Sales $800M, +8% as reported and constant currency, above guidance.
- GAAP EPS $2.50; non-GAAP EPS $3.40, up 16% YoY, above guidance.
- Pharma +11% cc; instruments +6%, recurring +9% cc; chemistry double-digit growth.
- FY25 constant currency sales growth guidance raised to +6.7% to +7.3%; non-GAAP EPS raised to $13.05-$13.15.
- Integration planning for BD Biosciences acquisition progressing; CEO confident in synergies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000697/000119312525263520/0001193125-25-263520-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000697/000119312525263520/d40092d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-263520

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer